Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Antus, G. Harnasi, O. Drozdovszky, I. Barta (Budapest, Hungary). Assessment of malondialdehyde in the airways during treatment of COPD exacerbations. Eur Respir J 2013; 42: Suppl. 57, 3558

Member's Comments

No comment yet.

Related content which might interest you: Monitoring catalase activity in COPD exacerbations Source: International Congress 2016 – Airway biomarkers Year: 2016 Monitoring oxidative stress during recovery from COPD exacerbations: Comparison of airway and systemic malondialdehyde levels Source: International Congress 2016 – Airway biomarkers Year: 2016 Malondialdehyde level in chronic obstructive pulmonary disease exacerbations Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Blood eosinophil guided prednisolone therapy for exacerbations of COPD: A further analysis Source: International Congress 2014 – COPD exacerbations Year: 2014 Cells biomarkers of bronchial brush-biopsies at COPD exacerbation Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system Year: 2013 Biomarkers in COPD exacerbation, the role of adiponectin Source: International Congress 2014 – Predictors Year: 2014 Role of inflammatory biomarkers in COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 Prediction of the duration of hospitilization in acute COPD exacerbations: The AECOPD-F score Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 Blood eosinophils and outcomes in COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Frequency of COPD exacerbations and severity of COPD Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Impact of mucolytic treatment on COPD exacerbations Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Evaluation of COPD exacerbations using the EXACT-U Source: Annual Congress 2010 - COPD exacerbation Year: 2010 Monitoring exhaled carbon monoxide in COPD exacerbations Source: International Congress 2014 – Airway biomarkers Year: 2014 BNP level in patients with COPD exacerbations Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Microbiological indicators from sputum of patients with exacerbation of COPD Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015 Neutrophil/lymphocyte (NLR) ratio in infectious acute exacerbations of COPD (AECOPD) Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Relationship of blood eosinophil count to exacerbations in COPD Source: International Congress 2016 – Airway response to infection Year: 2016